Common use

Provera contains medroxyprogesterone acetate, a synthetic progestin hormone that closely mimics the effects of naturally occurring progesterone in the female body. This versatile hormone therapy medication is primarily used to regulate ovulation and menstrual periods in women experiencing various gynecological conditions. Provera is prescribed for the treatment of secondary amenorrhea (the absence of menstrual periods in women who have previously menstruated), abnormal uterine bleeding caused by hormonal imbalance rather than structural causes such as fibroids or uterine cancer, and to reduce the incidence of endometrial hyperplasia in postmenopausal women receiving estrogen replacement therapy — thereby playing a crucial role in endometrial cancer prevention. Medroxyprogesterone works by stabilizing the uterine lining and promoting its orderly shedding, which helps restore a regular menstrual cycle in women with menstrual disorders. Many patients choose to buy Provera online for its well-documented efficacy and established safety record spanning decades of clinical use. Provera generic versions containing the same medroxyprogesterone active ingredient offer an equally effective treatment at a more affordable price, making essential hormone therapy accessible to more women who need progestin support for managing their gynecological health.



Dosage and direction

The typical dose of Provera is 5 to 10 mg taken once daily by mouth for 5 to 10 consecutive days, depending on the specific menstrual disorder being treated. Take medroxyprogesterone exactly as prescribed by your doctor — do not take larger amounts or use it for longer than recommended without medical guidance. For the treatment of amenorrhea, treatment usually begins with 5-10 mg daily for 5-10 days, with withdrawal bleeding typically occurring within three to seven days after completing the course. For abnormal uterine bleeding, your doctor may prescribe 5-10 mg daily for 5-10 days beginning on the calculated 16th or 21st day of your menstrual cycle. When used as part of hormone therapy for endometrial cancer prevention in postmenopausal women taking estrogen, Provera is typically administered at 5-10 mg daily for 12-14 consecutive days per month. Your doctor may schedule your treatment to begin on a specific day of your menstrual cycle for optimal effectiveness. While you are taking this progestin, perform monthly breast self-examinations to check for any lumps, changes in shape, or unusual discharge. Be aware that medroxyprogesterone may alter the results of certain medical and laboratory tests — always inform healthcare providers that you are taking this medication before undergoing any diagnostic procedures.



Precautions

Do not smoke while taking Provera, as combining smoking with progestin use significantly increases the risk of dangerous blood clotting events, including deep vein thrombosis and pulmonary embolism. Before starting hormone therapy with medroxyprogesterone, inform your doctor about all medical conditions that may require dose adjustment or additional monitoring, including: hypertension (high blood pressure), heart disease, recent stroke or heart attack, congestive heart failure, hypercalcemia (elevated calcium levels), high cholesterol or triglycerides, recent miscarriage or therapeutic abortion, severe pelvic pain, asthma, migraine headaches, epilepsy or seizure disorders, thyroid disorders, diabetes mellitus, kidney disease, systemic lupus erythematosus (lupus), and a personal or family history of depression. Regular medical follow-up appointments are essential during Provera treatment to monitor your response to hormone therapy and detect any potential complications early. Patients should be alert to signs of thromboembolic events (sudden leg pain or swelling, chest pain, shortness of breath, vision changes) and report them immediately to their healthcare provider. If you are scheduled for surgery, inform your surgeon that you are taking this progestin, as temporary discontinuation may be recommended to reduce clotting risk.



Contraindications

Provera is contraindicated in women who have known hypersensitivity to medroxyprogesterone acetate or any inactive ingredients in the formulation. Do not take this medication if you are pregnant, as progestins may cause harm to a developing fetus. Additional contraindications include: current or history of hormone-related cancer of the breast or reproductive organs, undiagnosed abnormal vaginal bleeding that has not been properly evaluated, active liver disease or a history of liver tumors, a personal history of stroke or blood clot (thromboembolism), active thrombophlebitis, and current breastfeeding (as medroxyprogesterone may pass into breast milk). Women with any of these conditions should not attempt to buy medroxyprogesterone without first obtaining a thorough medical evaluation and clearance from their healthcare provider. Alternative approaches to managing amenorrhea, abnormal bleeding, or endometrial cancer prevention should be discussed with your doctor if Provera is not appropriate for you.



Side effects

The most commonly reported side effects during Provera therapy include headache, dizziness, irritability, insomnia, drowsiness, fatigue, and depression. Gastrointestinal effects such as nausea and abdominal pain may also occur. Vascular-related adverse reactions include thrombophlebitis (inflammation of veins with clot formation) and cerebrovascular disorders, which require immediate medical attention. Breast-related side effects such as nipple tenderness, breast swelling, and galactorrhea (unexpected milk production) have been reported. Some women may experience changes in cervical mucus, cervical erosion, dysmenorrhea (painful periods), or alterations in menstrual flow patterns during hormone therapy. When medroxyprogesterone is administered at higher doses for extended periods, additional effects may include acne, hirsutism (increased facial or body hair), changes in body weight, moon face (facial fullness), elevated body temperature, and alopecia (hair thinning). Allergic reactions such as hives, skin rash, facial swelling, and difficulty breathing are possible but uncommon. Less frequent side effects include changes in libido, bloating, fluid retention, and mood swings. Report any severe, persistent, or concerning symptoms to your doctor promptly to determine whether adjustment of your progestin therapy is necessary.



Drug interaction

Aminoglutethimide is known to significantly reduce plasma concentrations of medroxyprogesterone, potentially decreasing the effectiveness of Provera for treating menstrual disorders or providing endometrial cancer prevention. Other enzyme-inducing medications, including rifampin, phenobarbital, phenytoin, and carbamazepine, may similarly accelerate the metabolism of this progestin and reduce its therapeutic efficacy. Inform your doctor about all prescribed and over-the-counter medications, herbal products (particularly St. John's wort), vitamins, and dietary supplements you are currently using. The concurrent use of medroxyprogesterone with certain other hormonal preparations may require dose adjustments or additional monitoring. Always discuss potential drug interactions before starting any new medication while on Provera hormone therapy to ensure your treatment plan remains effective and safe.



Missed dose

If you miss a dose of Provera, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose entirely and continue taking the medication according to your regular schedule. Never take a double dose of medroxyprogesterone to make up for a missed one, as this will not improve effectiveness and may increase the likelihood of side effects. If you are unsure about how to proceed after missing a dose, contact your doctor or pharmacist for guidance. Consistent daily adherence to your prescribed progestin schedule is important for achieving optimal treatment outcomes for your menstrual disorder or hormone therapy regimen.



Overdose

Symptoms of a Provera overdose may include dizziness, drowsiness, stomach pain, nausea, vomiting, breast tenderness, and vaginal bleeding. If you suspect you have taken more medroxyprogesterone than prescribed, seek immediate medical attention or contact a poison control center. While a single overdose of this progestin is unlikely to be life-threatening, medical monitoring and supportive care may be necessary. Treatment is generally symptomatic, as there is no specific antidote for medroxyprogesterone overdose. Your healthcare provider will assess your condition and provide appropriate supportive measures as needed.



Storage

Store Provera at room temperature between 20-25 C (68-77 F) in a dry, cool location protected from excessive moisture, direct heat, and sunlight. Keep the medication in its original packaging to protect the tablets from environmental degradation. Do not store in a bathroom medicine cabinet where humidity levels are elevated. Keep this and all hormone therapy medications securely out of reach of children and pets. Do not use medroxyprogesterone tablets that have passed their expiration date or show any visible signs of deterioration.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. The content is intended for educational purposes and should not replace professional medical advice. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.